Observational longitudinal data of individual biomarker levels (AFP) suggest that many patients who later go on to be diagnosed as developing HCC show a gradual (approximately log-linear) increase of their AFP biomarker level before being diagnosed with HCC [4]. The gene discussed is AFP; the disease is hepatocellular carcinoma.